WallStreetZenWallStreetZen

NASDAQ: ENTX
Entera Bio Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ENTX

Based on 4 analysts offering 12 month price targets for Entera Bio Ltd

Min Forecast
$9.00+206.12%
Avg Forecast
$9.75+231.63%
Max Forecast
$11.00+274.15%

Should I buy or sell ENTX stock?

Based on 5 analysts offering ratings for Entera Bio Ltd.

Strong Buy
Strong Buy
2 analysts 40%
Buy
3 analysts 60%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ENTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ENTX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their ENTX stock forecasts and price targets.

ENTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-25
lockedlocked$00.00+00.00%2026-09-23
lockedlocked$00.00+00.00%2026-09-22
lockedlocked$00.00+00.00%2026-09-18
lockedlocked$00.00+00.00%2026-04-27

1 of 1

Forecast return on equity

Is ENTX forecast to generate an efficient return?

Company
-978.42%
Industry
-16.04%
Market
156.35%
ENTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENTX forecast to generate an efficient return on assets?

Company
-364.95%
Industry
-2.83%
ENTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENTX earnings per share forecast

What is ENTX's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.43
Avg 3 year Forecast
-$0.41

ENTX revenue forecast

What is ENTX's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

ENTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTX$2.94$9.75+231.63%Strong Buy
CTMX$2.34$12.00+412.82%Strong Buy
FTH$19.44$57.00+193.21%Strong Buy
OCS$7.32$36.67+400.92%Strong Buy
VALN$5.51N/AN/A
View Top Biotech Stocks

Entera Bio Stock Forecast FAQ

Is Entera Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ENTX) stock is to Strong Buy ENTX stock.

Out of 5 analysts, 2 (40%) are recommending ENTX as a Strong Buy, 3 (60%) are recommending ENTX as a Buy, 0 (0%) are recommending ENTX as a Hold, 0 (0%) are recommending ENTX as a Sell, and 0 (0%) are recommending ENTX as a Strong Sell.

If you're new to stock investing, here's how to buy Entera Bio stock.

What is ENTX's earnings growth forecast for 2026-2028?

(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 65.64%.

Entera Bio's earnings in 2026 is -$17,033,000.On average, 7 Wall Street analysts forecast ENTX's earnings for 2026 to be -$71,092,036, with the lowest ENTX earnings forecast at -$88,233,077, and the highest ENTX earnings forecast at -$45,449,731. On average, 7 Wall Street analysts forecast ENTX's earnings for 2027 to be -$74,173,960, with the lowest ENTX earnings forecast at -$96,717,027, and the highest ENTX earnings forecast at -$63,629,623.

In 2028, ENTX is forecast to generate -$71,092,036 in earnings, with the lowest earnings forecast at -$74,658,758 and the highest earnings forecast at -$65,447,612.

What is ENTX's revenue growth forecast for 2026-2028?

(NASDAQ: ENTX) Entera Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 43.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.63%.

Entera Bio's revenue in 2026 is $0.On average, 7 Wall Street analysts forecast ENTX's revenue for 2026 to be $0, with the lowest ENTX revenue forecast at $0, and the highest ENTX revenue forecast at $0. On average, 7 Wall Street analysts forecast ENTX's revenue for 2027 to be $0, with the lowest ENTX revenue forecast at $0, and the highest ENTX revenue forecast at $0.

In 2028, ENTX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is ENTX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ENTX) forecast ROA is -364.95%, which is lower than the forecast US Biotechnology industry average of -2.83%.

What is ENTX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ENTX price target, the average ENTX price target is $9.75, with the highest ENTX stock price forecast at $11.00 and the lowest ENTX stock price forecast at $9.00.

On average, Wall Street analysts predict that Entera Bio's share price could reach $9.75 by Sep 25, 2027. The average Entera Bio stock price prediction forecasts a potential upside of 231.63% from the current ENTX share price of $2.94.

What is ENTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ENTX) Entera Bio's current Earnings Per Share (EPS) is -$0.35. On average, analysts forecast that ENTX's EPS will be -$0.41 for 2026, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.26. On average, analysts forecast that ENTX's EPS will be -$0.43 for 2027, with the lowest EPS forecast at -$0.56, and the highest EPS forecast at -$0.37. In 2028, ENTX's EPS is forecast to hit -$0.41 (min: -$0.43, max: -$0.38).

What is ENTX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ENTX) forecast ROE is -978.42%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.